Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
62%
OVERLAP
BY WEIGHT
15
# OF OVERLAPPING
HOLDINGS
OZEM
21
HOLDINGS
79%
ALSO IN THNR
THNR
19
HOLDINGS
83%
ALSO IN OZEM
SECTOR DRIFT (OZEM minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in OZEM |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 15.7% | 13.1% | 13.1% |
 |
NOVO-NORDISK A/S-SPONS ADR | 16.7% | 12.3% | 12.3% |
 |
ROCHE HOLDING LTD | 5.3% | 5.3% | 5.3% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 4.7% | 6.6% | 4.7% |
|
PFIZER INC | 3.8% | 4.9% | 3.8% |
OZEM Overweight Relative to THNR
|
VIKING THERAPEUTICS, INC. | 5.7% |
|
NOVO-NORDISK A/S-SPONS ADR | 4.4% |
|
TERNS PHARMACEUTICALS, INC. | 2.9% |
|
ELI LILLY & CO | 2.6% |
|
ZEALAND PHARMA A/S | 2.1% |
|
RHYTHM PHARMACEUTICALS, INC. | 2.0% |
|
GILEAD SCIENCES INC | 1.9% |
 |
HANMI PHARM CO LTD | 1.7% |
 |
THE UNITED LABORATORIES INTE | 0.6% |
|
SCHOLAR ROCK HOLDING CORP. | 0.5% |
OZEM Underweight Relative to THNR
|
ABBVIE INC | -5.1% |
|
MERCK & CO. INC. | -4.9% |
|
HIMS & HERS HEALTH, INC. CLASS A | -4.7% |
|
REGENERON PHARMACEUTICALS | -3.9% |
|
AMGEN INC | -3.3% |
|
SHIONOGI & CO LTD | -3.1% |
|
CHINA PHARMACEUTICAL GROUP | -2.6% |
|
CHUGAI PHARMACEUTICAL CO LTD | -2.0% |
 |
ASTRAZENECA PLC-SPONS ADR | -1.4% |
|
PFIZER INC | -1.1% |